Jacob Sands, MD
Dana-Farber Cancer Institute
3
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Gilbert Youssef, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Ravi Salgia, MD
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Chi-Fu Jeffrey Yang, MD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Evanthia Galanis, MD
Alliance Foundation Trials, LLC.
Shared therapeutic areas:
Worked with same sponsors:
Marc Fellous, MD
Sr. Vice President, Clinical Development and Medical Affairs
Shared therapeutic areas:
Joel W Neal, MD, PhD
Stanford University
Shared therapeutic areas:
Chandra Belani
ECOG-ACRIN Cancer Research Group
Shared therapeutic areas:
Akin Atmaca, PD Dr. med.
Krankenhaus Nordwest, Frankfurt, Deutschland
Shared therapeutic areas:
Kerry H Levin, M.D.
The Cleveland Clinic
Shared therapeutic areas:
Ningbo Liu, Doctor
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
All 3 trials loaded